KRTAP9-2
gene geneOn this page
Also known as KAP9.2
Summary
KRTAP9-2 (keratin associated protein 9-2, HGNC:16926) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 9-2 (Q9BYQ4). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the ultrahigh sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.
Source: NCBI Gene 83899 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_031961
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16926 |
| Approved symbol | KRTAP9-2 |
| Name | keratin associated protein 9-2 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP9.2 |
| Ensembl gene | ENSG00000239886 |
| Ensembl biotype | protein_coding |
| Entrez | 83899 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377721
RefSeq mRNA: 1 — MANE Select: NM_031961
NM_031961
CCDS: CCDS32651
Canonical transcript exons
ENST00000377721 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001474940 | 41226648 | 41227652 |
Expression profiles
Bgee: expression breadth broad, 21 present calls, max score 39.14.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 39.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| zone of skin | UBERON:0000014 | 36.95 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skin of leg | UBERON:0001511 | 35.69 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right lung | UBERON:0002167 | 33.62 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| liver | UBERON:0002107 | 30.57 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| right lobe of liver | UBERON:0001114 | 28.89 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| muscle of leg | UBERON:0001383 | 28.10 | gold quality |
| urinary bladder | UBERON:0001255 | 27.95 | silver quality |
| gastrocnemius | UBERON:0001388 | 27.60 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.28 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| leukocyte | CL:0000738 | 26.43 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| monocyte | CL:0000576 | 26.32 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting KRTAP9-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-892C-5P | 99.16 | 70.56 | 2116 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
| HSA-MIR-922 | 99.02 | 67.23 | 1838 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-6894-5P | 98.70 | 63.78 | 809 |
| HSA-MIR-3928-5P | 98.50 | 67.48 | 980 |
| HSA-MIR-6806-3P | 98.50 | 67.31 | 980 |
| HSA-MIR-541-5P | 98.24 | 67.77 | 1181 |
Cross-species orthologs
0 orthologs
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 9-2 — Q9BYQ4 (reviewed: Q9BYQ4)
Alternative names: Keratin-associated protein 9.2, Ultrahigh sulfur keratin-associated protein 9.2
All UniProt accessions (1): Q9BYQ4
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 9 family.
RefSeq proteins (1): NP_114167* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF13885
UniProt features (21 total): repeat 17, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYQ4-F1 | 37.55 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 25 (showing top):
TATA_C, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, TCANNTGAY_SREBP1_01, PEDRIOLI_MIR31_TARGETS_UP, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR570_3P, MIR494_3P, MIR892C_5P, MIR3123, TATA_01, MIR597_3P
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
402 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP9-2 | KRTAP13-1 | Q8IUC0 | 587 |
| KRTAP9-2 | KRTAP6-1 | Q3LI64 | 528 |
| KRTAP9-2 | SCYGR1 | A0A286YEY9 | 527 |
| KRTAP9-2 | KRT27 | Q7Z3Y8 | 526 |
| KRTAP9-2 | KRTAP13-2 | Q52LG2 | 524 |
| KRTAP9-2 | KRTAP20-1 | Q3LI63 | 507 |
| KRTAP9-2 | KRTAP19-3 | Q7Z4W3 | 503 |
| KRTAP9-2 | A8MUN0 | A8MUN0 | 502 |
| KRTAP9-2 | KRTAP1-4 | P0C5Y4 | 480 |
| KRTAP9-2 | KRT39 | Q6A163 | 479 |
| KRTAP9-2 | KRTAP19-2 | Q3LHN2 | 476 |
| KRTAP9-2 | KRTAP13-3 | Q3SY46 | 468 |
| KRTAP9-2 | KRTAP3-1 | Q9BYR8 | 447 |
| KRTAP9-2 | ZNF468 | Q5VIY5 | 444 |
| KRTAP9-2 | KRTAP6-3 | Q3LI67 | 414 |
IntAct
656 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LCE1B | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.790 |
| KRTAP9-2 | LCE1B | psi-mi:“MI:0915”(physical association) | 0.790 |
| KRTAP10-9 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| LCE4A | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| KRTAP9-2 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.740 |
| KRTAP9-2 | LCE4A | psi-mi:“MI:0915”(physical association) | 0.740 |
| KRTAP9-2 | PRKAB2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | HOXA1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | KRTAP10-11 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CREB5 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| JOSD1 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE2A | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP5-6 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | CATSPER1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | PTPMT1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NTAQ1 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NUFIP2 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | GLRX3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP5-9 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| OTX1 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SMCP | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (183): KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: A5A6P5, Q9BYP9, Q9BYQ0, Q9BYQ2, Q9BYQ3, Q9BYQ4, A8MVA2, A8MTY7
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 20 | 24.8× | 2e-21 |
| Formation of the cornified envelope | 8 | 15.6× | 2e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 7 | 32.8× | 6e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
239 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41227378:A:AG | acceptor_gain | 0.8300 |
| 17:41227384:T:TA | acceptor_gain | 0.8300 |
| 17:41227379:C:G | acceptor_gain | 0.8000 |
| 17:41227310:T:G | acceptor_gain | 0.7900 |
| 17:41227376:A:AG | acceptor_gain | 0.7800 |
| 17:41227475:G:GT | donor_gain | 0.7600 |
| 17:41227385:G:A | acceptor_gain | 0.7300 |
| 17:41227378:ACCTT:A | acceptor_gain | 0.7200 |
| 17:41227339:G:T | donor_gain | 0.6800 |
| 17:41226726:G:GT | donor_gain | 0.6600 |
| 17:41227377:C:G | acceptor_gain | 0.6400 |
| 17:41227448:TC:T | donor_gain | 0.6300 |
| 17:41227338:G:GT | donor_gain | 0.6100 |
| 17:41227466:GCTTC:G | donor_gain | 0.6100 |
| 17:41227415:GTT:G | donor_gain | 0.6000 |
| 17:41227416:TTT:T | donor_gain | 0.6000 |
| 17:41227529:A:AG | acceptor_gain | 0.6000 |
| 17:41227382:T:A | acceptor_gain | 0.5900 |
| 17:41227408:TTCTC:T | donor_gain | 0.5900 |
| 17:41227470:C:G | donor_gain | 0.5900 |
| 17:41227479:T:TG | donor_gain | 0.5900 |
| 17:41226836:GCT:G | donor_gain | 0.5600 |
| 17:41227479:T:G | donor_gain | 0.5500 |
| 17:41227107:G:GT | donor_gain | 0.5400 |
| 17:41227572:T:G | acceptor_gain | 0.5400 |
| 17:41226926:G:GG | donor_gain | 0.5300 |
| 17:41227122:G:GT | donor_gain | 0.5300 |
| 17:41227470:C:CG | donor_gain | 0.5300 |
| 17:41227487:C:G | donor_gain | 0.5300 |
| 17:41227571:AT:A | acceptor_gain | 0.5300 |
AlphaMissense
1147 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41227012:T:C | C120R | 0.754 |
| 17:41227008:A:C | R118S | 0.743 |
| 17:41227008:A:T | R118S | 0.743 |
| 17:41227014:C:G | C120W | 0.700 |
| 17:41227015:T:G | Y121D | 0.699 |
| 17:41227002:C:G | C116W | 0.675 |
| 17:41226874:A:C | S74R | 0.652 |
| 17:41226876:C:A | S74R | 0.652 |
| 17:41226876:C:G | S74R | 0.652 |
| 17:41227000:T:C | C116R | 0.627 |
| 17:41226790:A:C | S46R | 0.621 |
| 17:41226792:C:A | S46R | 0.621 |
| 17:41226792:C:G | S46R | 0.621 |
| 17:41227132:T:C | F160L | 0.621 |
| 17:41227134:C:A | F160L | 0.621 |
| 17:41227134:C:G | F160L | 0.621 |
| 17:41227045:T:C | C131R | 0.611 |
| 17:41227012:T:A | C120S | 0.598 |
| 17:41227013:G:C | C120S | 0.598 |
| 17:41227013:G:A | C120Y | 0.589 |
| 17:41227015:T:C | Y121H | 0.577 |
| 17:41227047:C:G | C131W | 0.577 |
| 17:41227176:C:G | C174W | 0.575 |
| 17:41227022:C:A | P123H | 0.568 |
dbSNP variants (sampled 300 via entrez): RS1000295991 (17:41238395 G>A), RS1000453506 (17:41224716 T>C), RS1000588471 (17:41224956 C>G), RS1000856489 (17:41225567 T>G), RS1001119976 (17:41238249 C>G,T), RS1001857195 (17:41226893 G>A), RS1002262875 (17:41226126 T>C), RS1002636836 (17:41237687 G>A,C), RS1003098964 (17:41237467 A>G), RS1003748641 (17:41237370 G>A), RS1004344091 (17:41226093 T>G), RS1004822199 (17:41225772 G>A), RS1005086492 (17:41226981 C>T), RS1006037565 (17:41237901 G>A,T), RS1006294509 (17:41228055 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.